研究者業績

江﨑 幸生

esaki kosei

基本情報

所属
藤田医科大学 医学部 医学科 精神神経科学 講師
学位
博士(医学)

J-GLOBAL ID
201501016839330669
researchmap会員ID
7000013114

MISC

 10
  • Takeo Saito, Kenji Kondo, Yoshimi Iwayama, Ayu Shimasaki, Branko Aleksic, Kazuo Yamada, Tomoko Toyota, Eiji Hattori, Kosei Esaki, Hiroshi Ujike, Toshiya Inada, Hiroshi Kunugi, Tadafumi Kato, Takeo Yoshikawa, Norio Ozaki, Masashi Ikeda, Nakao Iwata
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 165(5) 421-427 2014年7月  査読有り
    Recent genome-wide association studies (GWASs) of schizophrenia (SCZ) identified several susceptibility genes and suggested shared genetic components between SCZ and bipolar disorder (BD). We conducted a genetic association study of single nucleotide polymorphisms (SNPs) selected according to previous SCZGWA Stargeting psychotic disorders (SCZ and BD) in the Japanese population. Fifty-one SNPs were analyzed in a two-stage design using first-set screening samples (all SNPs: 1,032 SCZ, 1,012 BD, and 993 controls) and second-set replication samples ("significant" SNPs in the first-set screening analysis: 1,808 SCZ, 821 BD, and 2,321 controls). We assessed allelic associations between the selected SNPs and the three phenotypes (SCZ, BD, and "psychosis" [SCZ + BD]). Nine SNPs revealed nominal association signals for all comparisons (P-uncorrected < 0.05), of which two SNPs located in the major histocompatibility complex region (rs7759855 in zincfinger and SCAN domain containing 31 [ZSCAN31] and rs1736913 in HLA-F antisense RNA1 [HLA-F-AS1]) were further assessed in the second-set replication samples. The associations were confirmed for rs7759855 (P-corrected = 0.026 for psychosis; P-corrected = 0.032 for SCZ), although the direction of effect was opposite to that in the original GWAS of the Chinese population. Finally, a meta-analysis was conducted using our two samples and using our data and data from Psychiatric GWAS Consortium (PGC), which have shown the same direction of effect. SNP in ZSCAN31 (rs7759855) had the strongest association with the phenotypes (best P = 6.8 x 10(-5) for psychosis: present plus PGC results). These data support shared risk SNPs between SCZ and BD in the Japanese population and association between MHC and psychosis. (C) 2014 Wiley Periodicals, Inc.
  • Kosei Esaki, Kenji Kondo, Masakazu Hatano, Takeo Saito, Taro Kishi, Wakako Umene-Nakano, Reiji Yoshimura, Jun Nakamura, Norio Ozaki, Masashi Ikeda, Nakao Iwata
    JOURNAL OF HUMAN GENETICS 58(8) 568-569 2013年8月  査読有り
  • Motoshi Asano, Kosei Esaki, Aya Wakamatsu, Tomoko Kitajima, Tomohiro Narita, Hiroshi Naitoh, Norio Ozaki, Nakao Iwata
    PSYCHIATRY AND CLINICAL NEUROSCIENCES 67(5) 340-344 2013年7月  
    Aims: The purpose of this study was to predict the outcome of cognitive behavior therapy (CBT) by trainees for major depressive disorder (MDD) based on the Parental Bonding Instrument (PBI). The hypothesis was that the higher level of care and/or lower level of overprotection score would predict a favorable outcome of CBT by trainees. Methods: The subjects were all outpatients with MDD treated with CBT as a training case. All the subjects were asked to fill out the Japanese version of the PBI before commencing the course of psychotherapy. The difference between the first and the last Beck Depression Inventory (BDI) score was used to represent the improvement of the intensity of depression by CBT. In order to predict improvement (the difference of the BDI scores) as the objective variable, multiple regression analysis was performed using maternal overprotection score and baseline BDI score as the explanatory variables. Results: The multiple regression model was significant (P=0.0026) and partial regression coefficient for the maternal overprotection score and the baseline BDI was -0.73 (P=0.0046) and 0.88 (P=0.0092), respectively. Therefore, when a patient's maternal overprotection score of the PBI was lower, a better outcome of CBT was expected. Conclusion: The hypothesis was partially supported. This result would be useful in determining indications for CBT by trainees for patients with MDD.
  • 内藤宏, 江崎幸生, 成田智拓
    精神科 23(1) 79-85 2013年  
  • 内藤 宏, 江崎幸生
    MB ENTONI 160 56-62 2013年  
  • 内藤宏, 江崎幸生
    精神科 23(1) 79-85 2013年  
  • 内藤宏, 江崎幸生
    ENTONI 160 56-62 2013年  
  • 内藤宏, 江崎幸生
    ホルモンと臨床 60 65-72 2012年  
  • 佐野亘, 江崎幸生, 岩田仲生
    精神科 15 188-193 2009年  
  • 江崎幸生, 木村宏之
    精神療法 34(6) 83-92 2008年  

書籍等出版物

 2

講演・口頭発表等

 7